Tillbaka till portföljen

TMSNeurostimulationFDA-ClearedBrain Mapping
Investerat
2019
Grundat
2000
Huvudkontor
Helsinki, Finland
Sektor
MedTech
Om
Nexstim develops navigated transcranial magnetic stimulation (nTMS) systems with their SmartFocus® technology, delivering unmatched accuracy through advanced 3D imaging. Their NBS System 5 and 6 are used for brain surgery planning, depression treatment, post-operative rehabilitation, epilepsy management, and pain relief, with FDA clearance, EU MDR certification, and expanding international presence.